Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanlishuang Buccal Dropping Pills is a traditional Miao medicine (a subset of Traditional Chinese Medicine) used for the treatment of acute pharyngitis and associated symptoms such as sore throat and pain on swallowing. Formulated as a dropping pill for buccal administration, it provides local anti-inflammatory, analgesic, and antimicrobial effects. The preparation typically contains a mixture of botanical extracts and aromatic compounds, including menthol, borneol, *Acorus tatarinowii*, and licorice. It works by soothing the inflamed pharyngeal mucosa and providing a cooling sensation that rapidly alleviates pain. Clinical trials, including multicenter, randomized, double-blind studies, have been conducted to evaluate its efficacy and safety in adult populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanlishuang Buccal Dropping Pills.